Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison
- 30 September 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 213 (2) , 195-202
- https://doi.org/10.1016/j.canlet.2004.05.017
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9)Pharmacogenetics, 2003
- Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from IranInternational Journal of Cancer, 2003
- Angular regression and the detection of the seasonal onset of disease.Journal of Cancer Epidemiology and Prevention, 2002
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Identification of a Single Nucleotide Polymorphism in the TATA Box of the CYP2A6 Gene: Impairment of Its Promoter ActivityBiochemical and Biophysical Research Communications, 2001
- Frequency ofCYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese populationInternational Journal of Cancer, 2001
- Genetic Polymorphisms of Tobacco- and Alcohol-Related Metabolizing Enzymes and Human Esophageal Squamous Cell Carcinoma SusceptibilityJournal of Clinical Gastroenterology, 1997
- CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagusInternational Journal of Cancer, 1997
- Oesophageal Cancer Studies in the Caspian Littoral of Iran: The Caspian Cancer RegistryBritish Journal of Cancer, 1973
- Differences Observed in the Site Incidence of Cancer, Between the Parsi Community and the Total Population of Greater Bombay: A Critical AppraisalBritish Journal of Cancer, 1970